Bifogade filer
Kurs & Likviditet
Beskrivning
Land | Danmark |
---|---|
Lista | First North Stockholm |
Sektor | Hälsovård |
Industri | Bioteknik |
Hørsholm, Denmark, March 9, 2022 - ExpreS2ion Biotech Holding AB's affiliate ExpreS2ion Biotechnologies ApS ("ExpreS2ion") will participate and hold presentations at key industry and investor events in March. These include Aktiespararna's Aktiedagen (March 14), the Swiss Nordic Bio event (March 23), and BIO-Europe Spring (March 28-31).
By attending relevant industry and investor events, the company aims to increase the awareness of the ExpreS[2] technology platform and its exciting development pipeline, including the novel ES2B-C001 HER2-cVLP breast cancer vaccine. More information on each event and how to register is found below.
Aktiespararna's Aktiedagen, March 14, at 20.00-20.30
See the company presentation by our CEO Bent U. Frandsen at this investor event. It is possible to follow the event online, or attend the meeting by reserving a seat at Aktiespararna's website (https://www.aktiespararna.se/aktiviteter/aktiedagen-stockholm-14-15-mars-2022).
Swiss Nordic Bio, Zürich, Switzerland, March 23
To pre-arrange investor/business meetings with our CEO Bent U. Frandsen, please contact us via email on info@expreS2ionbio.com.More information is available at the event website Swiss Nordic Bio (https://www.swissnordicbio.com/).
BIO-Europe Spring, March 28-31, Digital
To pre-arrange business meetings with ExpreS[2]ion representatives, please contact us via email on info@expreS2ionbio.com.More information is available at BIO-Europe's website (https://informaconnect.com/bioeurope-spring/).
Certified Adviser
Svensk Kapitalmarknadsgranskning AB
Telefon: +46 11 32 30 732
E-post: ca@skmg.se